Status:
UNKNOWN
Validation of a New Generation of Orthopedic Brace for Treating Adolescent Idiopathic Scoliosis by Using Growth Modulation
Lead Sponsor:
St. Justine's Hospital
Conditions:
Scoliosis
Adolescent Idiopathic Scoliosis
Eligibility:
All Genders
10-16 years
Phase:
NA
Brief Summary
Adolescent Idiopathic Scoliosis affects 3-4% of the Canadian population, of which about 10% will need a brace treatment during pubertal growth spurt. Our team has developed an innovative conception me...
Eligibility Criteria
Inclusion
- AIS diagnosis
- Risser 0-2
- Primary curve angles 20 degrees - 40 degrees
- If female, either premenarchal or less than 18 months postmenarchal.
Exclusion
- Patients with a pre-existing cardiovascular condition
- Patients with a symptom of a neurological disorder
- Patients with any other disorder of the musculoskeletal system affecting the lower limbs
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04889339
Start Date
June 1 2021
End Date
January 1 2024
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5